• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Inhibikase Therapeutics Reports Q2 Financial Results And Recent Activity

    GLOBENEWSWIRE

    Inhibikase Completes Enrollment Of Phase 2 Trial For Risvodetinib In Parkinson’s

    GLOBENEWSWIRE

    Inhibikase Therapeutics to Provide Trial Update for Risvodetinib

    GLOBENEWSWIRE

    Inhibikase Announces Publication Highlighting Results from Ph 1 with Risvodetinib

    GLOBENEWSWIRE

    Inhibikase Highlights Functional Analysis from the 201 Trial of Risvodetinib

    GLOBENEWSWIRE

    Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.